About Cadila Pharmaceuticals Limited
Data last updated: 09 December 2025
Cadila Pharmaceuticals Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 28 February 1991, the company has been in operation for over 35 years.
Registered with ROC Ahmedabad under CIN U24231GJ1991PLC015132.
Capital: an authorised share capital of ₹120.65 Cr and a paid-up capital of ₹80.01 Cr. Formerly known as Nova Biotics (India) Pvt Ltd and Nova Biostic (India) Private Limited. It is led by directors including Rajiv Rajiv Modi and Subir Kumar Das.
Last AGM: 14 August 2024. Financial statements filed for year ended 31 March 2024. Office: Cadila Corporate Campus Sarkhej Dholka Road Bhat, Ahmedabad, Gujarat, India – 382210.
As per the financials filed for FY 2025, the company reported a revenue of ₹3,869.17 Cr, a growth of 4% compared to the previous year.
The company has a workforce of approximately 6,144 employees as per the latest available data. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand - Cadila Pharmaceuticals Limited. As per MCA filings, the company has open charges of ₹4,155.28 Cr and satisfied charges of ₹3,605.28 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cadilapharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressCadila Corporate Campus Sarkhej Dholka Road Bhat, Ahmedabad, Gujarat, India – 382210
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited has undergone 3 name changes throughout its history. The company was previously known as Nova Biotics (India) Pvt Ltd, Nova Biostic (India) Private Limited, and Cadila Pharmaceuticals Private Limited. The current legal name is Cadila Pharmaceuticals Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Cadila Pharmaceuticals Limited | Current |
| Nova Biotics (India) Pvt Ltd | Previous |
| Nova Biostic (India) Private Limited | Previous |
| Cadila Pharmaceuticals Private Limited | Previous |
CIN History of Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited has one previous CIN (Corporate Identification Number): U24231GJ1991PTC015132. The current CIN is U24231GJ1991PLC015132, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231GJ1991PLC015132 | Current |
| U24231GJ1991PTC015132 | Previous |
Associated Brands with Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited operates one associated brand: Cadila Pharmaceuticals Limited. These brands represent Cadila Pharmaceuticals Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products are manufactured for multiple therapeutic areas. | cadilapharma.com |
Business Activity of Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Cadila Pharmaceuticals Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited is audited by MUKESH M. SHAH & CO. for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MUKESH M. SHAH & CO. | Locked | Locked | Locked |
Complete auditor history for Cadila Pharmaceuticals Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited is currently managed by 6 directors, with 34 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Rajiv Rajiv Modi
Also directs:
Irm Energy Limited, Cpl Biologicals Private Limited, La Vie Biologicals Private Limited and 5 more
|
Director | 18 Jul 2024 | 2 Years 0 Months | Current |
|
Subir Kumar Das
Also directs:
Irm Enterprises Private Limited, Transformers And Rectifiers (India) Limited, M & B Engineering Limited and 2 more
|
Additional Director | 30 Jun 2025 | 1 Years 1 Months | Current |
|
Parul Nikunj Shah
Also directs:
Irm Enterprises Private Limited
|
Additional Director | 01 Dec 2023 | 2 Years 8 Months | Current |
| Rajiv Indravadan Modi | Managing Director | 28 Feb 1991 | 35 Years 5 Months | Current |
| Girdhar Prem Balwani | Director | 01 May 2017 | 9 Years 3 Months | Current |
|
Ramesh Ratilal Choksi
Also directs:
Cpl Biologicals Private Limited, La Vie Biologicals Private Limited, Gig - Irm Glass Insulators Private Limited and 5 more
|
Whole-Time Director | 07 Feb 2014 | 12 Years 6 Months | Current |
Financials of Cadila Pharmaceuticals Limited FY 2024 filings available
Cadila Pharmaceuticals Limited reported revenue of ₹3,869.17 Cr (up 4.00% YoY) for FY 2025.
Ten-year financial statements for Cadila Pharmaceuticals Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Cadila Pharmaceuticals Limited
Shareholding and ownership data for Cadila Pharmaceuticals Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited has 2 subsidiary companies. This group structure data is as of FY 2024. The corporate group structure reflects Cadila Pharmaceuticals Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Cpl Biologicals Private Limited | U01403GJ2009PTC056409 | Locked |
| Cpl Pharmaceuticals Private Limited | U24299GJ2021PTC119244 | Locked |
Showing major subsidiaries. Total: 2.
Charges & Borrowings of Cadila Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Oct 2025 | Others | ₹5 Cr | Open |
| 08 Sep 2025 | Indian Bank | ₹260 Cr | Open |
| 16 Jun 2025 | Others | ₹216 Cr | Open |
| 05 Jun 2025 | Others | ₹50 Cr | Open |
| 27 Mar 2025 | Others | ₹100 Cr | Open |
Total charge records: 90 View all charges
Employees and EPFO Compliance at Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited has a workforce of 6,144 employees as of Sep 23, 2025.
Employee and EPFO history for Cadila Pharmaceuticals Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Cadila Pharmaceuticals Limited
GST registrations and filing compliance for Cadila Pharmaceuticals Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Cadila Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts for Cadila Pharmaceuticals Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cadila Pharmaceuticals Limited
MSME payment history for Cadila Pharmaceuticals Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cadila Pharmaceuticals Limited
Corporate group structure for Cadila Pharmaceuticals Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cadila Pharmaceuticals Limited
MCA filings and documents for Cadila Pharmaceuticals Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Cadila Pharmaceuticals Limited
Recent News on Cadila Pharmaceuticals Limited
Frequently Asked Questions about Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 28 February 1991 (35+ years old) and is registered under CIN U24231GJ1991PLC015132. The company has 6,144 employees.
Cadila Pharmaceuticals Limited reported revenue of ₹3,869.17 Cr for FY 2025 (up 4.00% YoY).
The current directors of Cadila Pharmaceuticals Limited are:
- Rajiv Rajiv Modi - Director
- Subir Kumar Das - Additional Director
- Parul Nikunj Shah - Additional Director
- Rajiv Indravadan Modi - Managing Director
- Girdhar Prem Balwani - Director
- Ramesh Ratilal Choksi - Whole-Time Director
The primary industry of Cadila Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Cadila Pharmaceuticals Limited can be reached at the registered office: Cadila Corporate Campus Sarkhej Dholka Road Bhat, Ahmedabad, Gujarat, India – 382210, or through the website cadilapharma.com.
The authorised capital is ₹120.65 Cr, and the paid-up capital is ₹80.01 Cr.